Respiratory Infection, Respiratory Infection Bacterial, Respiratory Infections in Old Age, Respiratory Infection Virus
Conditions
Brief summary
The goal of this observational study is to compare the results of a serum biomarker called the MeMed BV®, which is approved to help differentiate between bacterial and viral respiratory infections, to clinical diagnoses of adult emergency department patients presenting with recent fever and signs or symptoms of a respiratory infection. Active participation is completed during the emergency department visit and includes drawing blood, obtaining a sputum sample, and answering survey questions.
Detailed description
The MeMed BV® is a diagnostic test newly approved by the FDA to assess the likelihood of bacterial vs. viral respiratory infections based on protein biomarkers in blood. This study aims to identify the level of agreement between the results of the MeMed BV® (bacterial/viral) and the standard of care treatment received by the participant (e.g. antibiotics for patient diagnosed with bacterial pneumonia) in order to see if implementing the MeMed BV® into standard clinical care would potentially change diagnosis.
Interventions
DIAGNOSTIC_TESTMeMed BV® test
The MeMed BV® test is an automated semiquantitative immunoassay that measures three nonmicrobial (host) proteins (TRAIL, IP-10, and CRP) in serum samples and is intended for use in conjunction with clinical assessments and other laboratory findings as an aid to differentiate bacterial from viral infection.
Sponsors
University of Wisconsin, Madison
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Adults presenting to the emergency department * Subjective or objective fever within the past 7 days * Signs or symptoms of upper or lower respiratory tract infection within the past 7 days
Exclusion criteria
* Prisoner * Suspicion and/or confirmed diagnosis of infectious gastroenteritis/colitis * Active inflammatory disease * Congenital or acquired immune deficiency * Chronic fungal or parasitic infection * Infection with human immunodeficiency virus (HIV) * Hepatitis B virus (HBV) * Hepatitis C virus (HCV) * Infection with active tuberculosis (TB) * Significant trauma or burns in the last 7 days * Patients that have undergone major surgery in the last 7 days * Pregnancy * Active malignancy
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| MeMed BV® test result and diagnostic concordance | Emergency department 1 day visit | Percent agreement between result of MeMed BV® test (bacterial or viral respiratory infection) and antibiotic prescribing by emergency medicine doctor (which implies suspected bacterial infection) |
Countries
United States
Outcome results
None listed